Karnataka is planning to establish a ‘Pharma Park’ which will give much needed fillip for manufacture and also woo the potential investors into the state. The state government has identified a few locations and is expected to finalise the same at the earliest.
In this regard, the Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA) is now in the process of evaluating the feasibility of these sites. These include Nanjangud in Mysuru, Chamrajanagar off Mysuru, Kanakapura in the outskirts of Bengaluru and Hubballi-Dharwad in north Karnataka.
These according to the state government are viewed to be promising locations for Pharma Park going by the access to manpower, Water and other logistics. However, another key factor being assessed is the clearance from the Pollution Control Board.
The key objective for the government is to ensure that Karnataka is a preferred destination for pharmaceuticals going by the presence of large number of good pharmacy and engineering colleges making access to qualified pool of workforce for research, quality control, regulatory, marketing and manufacture, Harish K Jain, Secretary, KDPMA and Director, Embiotic Laboratories told.
Moreover the state government has assured its support and encouragement for the initiative by way of land, incentives, common facilities, infrastructure etc, he added.
Another move by the government to support the growth of the pharma industry and its recognition as a knowledge driven sector was the formation of the Vision Group on Pharmaceuticals which is now seen to be a catalyst to spur development, noted Jain.
“We are also actively working in this direction and shall very shortly file Preliminary Application form with the State Department of Industries & Commerce. This will be quickly followed by filing of Project Proposal and Diagnostic Study Report for In-Principal Approval”, he said.
The key takeaways of the Pharma Park would be making available developed land with all infrastructure and common facilities at a reasonable price. This allows the entrepreneurs to concentrate on their core activity of manufacture and marketing. The concept of a Pharma Park allows reduction of capital cost for small and medium enterprises specifically to invest in putting up plant as well as running cost, while reducing compliance burden of departments like Pollution Control. Once these challenges of commissioning a stand-alone manufacturing plant are taken care with a dedicated industrial park, it would eventually lead to reduced cost of production. The entrepreneurs thereby can maximise the ease of doing business, stated Jain.
Source : www.pharmabiz.com
Published on: October 24, 2017